期刊文献+

膜联蛋白A1在前列腺癌中的表达及意义 被引量:3

Expression and significance of annexin A1 in prostatic cancer
原文传递
导出
摘要 目的:探讨膜联蛋白A1在前列腺癌组织、癌旁组织及正常前列腺组织中的表达及意义。方法:应用免疫组织化学SABC法检测膜联蛋白A1在61例前列腺癌组织、40例癌旁组织、40例正常前列腺组织中的表达,分析其在不同组织中表达情况。结果:在前列腺癌组织、癌旁组织、正常前列腺组织中膜联蛋白A1的阳性表达率分别为19.67%,22.50%和72.50%(P<0.01)。前列腺癌组织中膜联蛋白A1表达在年龄、肿瘤大小、组织分化程度、肿瘤浸润深度、有无淋巴结转移、TNM分期及远处转移等方面差异均无统计学意义(P>0.05)。结论:膜联蛋白A1表达异常可能成为前列腺癌早期诊断的重要指标。 Objective To study the expression and significance of annexin A1 in prostatic cancer tissue,normal tumor-adjacent tissue and normal prostate mucosa tissue.Methods The expression of annexin A1 was examined with immunohistochemical SABC method in 40 cases of normal prostate tissue,40 cases of normal tumor-adjacent tissue and 61 cases of prostatic cancer tissue.Results The expression rates of annexin A1 were 19.67%,22.5% and 72.5% in prostatic cancer tissue,normal tumor-adjacent tissue and normal prostate mucosa tissue(P〈0.01).There were no significant differences in annexin A1 expressions in age,tumor size,tissue differentiation degree,tumor infiltration depth,lymph node metastasis,TNM staging or distant metastasis(P〈0.05).Conclusion Abnormal annexin A1 expression may be an important index for the early diagnosis of prostate cancer.
出处 《中华实用诊断与治疗杂志》 2011年第8期735-736,共2页 Journal of Chinese Practical Diagnosis and Therapy
基金 甘肃省科技厅自然科学基金资助项目(1007RJYA022)
关键词 前列腺癌 膜联蛋白A1 免疫组织化学 Prostatic carcinoma annexin A1 immunohistochemistry
  • 相关文献

参考文献9

  • 1卢永宁,陈斌.前列腺癌高特异性标志物DD3基因研究进展[J].实用诊断与治疗杂志,2008,22(4):282-285. 被引量:2
  • 2李玉芳,温敏.产科弥漫性血管内凝血44例临床分析[J].实用诊断与治疗杂志,2008,22(6):476-477. 被引量:5
  • 3Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs[J]. Cancer Res, 1998,58(23):5315-5320.
  • 4薛燕平,涂学亮,王巍魏.复合前列腺特异性抗原、总前列腺特异性抗原及其比值在前列腺癌诊断中的应用[J].中华实用诊断与治疗杂志,2009,23(4):356-358. 被引量:4
  • 5李一 钱晨 钱增喜 等.膀胱全切原位w形回肠代膀胱术治疗膀胱癌疗效观察.实用诊断与治疗杂志,2006,20(7):379-382.
  • 6曲利娟 彭少华 吴得昌 等.Annexin-1在a粒子转化细胞及肺癌组织中高表达.诊断病理学杂志,2007,14(2):211-212.
  • 7de Coupade C, Gillet R, Bennoun M, et al. Annexin-1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin Ⅲ SV40 T large antigen transgenic mice[J]. Hepatology, 2000,31(2) : 371-380.
  • 8吴阶平,顾方六.吴阶平泌尿外科[M].7版.济南:山东科学技术出版社,2004:889-918.
  • 9Emmert-Buck M R, Gillespie J W, Paweletz C P, et al. An approach to proteomic analysis of human tumors [J]. Mol Carcinog,2000,27(3): 158-165.

二级参考文献30

  • 1刘楚芹,李奇艳.肝素防治产科播散性血管内凝血的临床观察[J].中国基层医药,2004,11(6):677-678. 被引量:7
  • 2尹春艳,王玲,张翠琼,周敬珍,王保平,吕小燕,周长华,贾晓江.成分输血在抢救产科急性DIC中的应用[J].中国输血杂志,2005,18(4):322-323. 被引量:5
  • 3王智勇,张卫星,王瑞.PTTG和b-FGF在前列腺癌中的表达与临床病理学特征的相关性研究[J].实用诊断与治疗杂志,2006,20(8):577-579. 被引量:10
  • 4陶志华,毛晓露,王彩虹,陈晓东,余凯远,翁志梁,胡元平,张筱骅,谢辉,王瓯晨,宋其同,李澄棣,陈占国.DD3 mRNA在前列腺癌组织中定量表达分析[J].中华男科学杂志,2007,13(2):130-133. 被引量:15
  • 5单渊东 张之南.播散性血管内凝血的诊断和治疗[J].中华内科杂志,1983,8:514-514.
  • 6Mistry K, Cable G. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma [J]. J Am Board Fam Pract, 2003, 16(2):95-101.
  • 7Hessels D, Klein Gunnewiek JMT, van Oort I, et al. DD3 (PCA3)-based molecular urine analysis for the diagnosis of prostate cancer[J]. Eur Urol, 2003, 44(1):8-15.
  • 8Bussemakers M J, van Bokhoven A, Verhaegh G W, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer[J]. CancerRes, 1999, 59(23) :5975-5979.
  • 9Schalken J A, Hessels D, Verhaegh G. New targets for therapy in prostate cancer: differential display code 3 (DD3 (PCA3)), a highly prostate cancer-specific gene[J]. Urology, 2003, 62 (5 Suppl 1) :34-43.
  • 10de Kok J B, Verhaegh G W, Roelofs R W, et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors[J]. Cancer Res, 2002,62(9) :2695-2698.

共引文献8

同被引文献41

  • 1李翠联,陈世伦,陈文明,刘敬忠,肖白,张海波.三氧化二砷改变多发性骨髓瘤细胞基因表达的研究[J].中华血液学杂志,2005,26(4):209-213. 被引量:6
  • 2Strope S A, Andriole G L. Prostate cancer screening: current status and future perspectives[J].Nat Rev Urol, 2010, 7(9) :487-493.
  • 3Li Y D, Li Y H, Zhao Y, et al. Preparation of human scFv antibody against nasopharyngeal carcinoma and iden- tification of its specificity [ J ]. Acta Otolaryngol, 2012, 132(6) :663-670.
  • 4Yang T, Yang L J. A strategy for high-level expression of a single-chain variable fragment against TNF-oL by sub- cloning antibody variable regions from the phage display vector Pcantab 5E into pBV220[J]. Protein Expr Purif, 2011, 76(1) :109-114.
  • 5Velappan N, Martinez J S, Valero R, et al. Selection and characterization of scFv antibodies against the Sin Nom-brehantavirus nucleocap sid protein [ J ]. J Immunol Methods, 2007, 321 (1-2) :60-69.
  • 6Kioi M, Seetharam S, Purl R K. Targeting IL213Ralpha2 positive cancerwith a novel recombinant immunotoxin composed of a single2chain antibody and mutated Pseudo- monas exotoxin [J]. Mol Cancer Ther, 2008, 7 ( 6 ) : 1579-1587.
  • 7Douguchi J, Hashiguchi A, Sakamoto M. Construction of human monoclonal single-chain Fv antibodies against small-cell lung cancer by phage display libraries derived from cell-immunized SCID mice engrafted with human peripheral blood lymphocytes[J].Proteomics Clin Ap- pl, 2009, 3(11) :1265-1272.
  • 8Wang X, Katayama A, Wang Y, et al. Functional char- acterization of an scFv-Fc antibody that immunotherapeu- tically targets the common cancer cell surface proteogly- can CSPG4[J]. Cancer Res, 2011, 71(24):7410- 7422.
  • 9Muller B H, Savatier A, L' Hostis G, et al. In vitro af- finity maturation of an anti-PSA antibody for prostate cancer diagnostic assay[J]. J Mol Biol, 3011,414(4) : 545 -562.
  • 10Zhou Y, Marks J D. Discovery of internalizing antibod- ies to tumor antigens from phage libraries [J]. Methods Enzymol, 2012, 502:43-66.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部